Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.08836028 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08836028 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96719941 |
4 | negative regulation of cell killing (GO:0031342) | 4.83349541 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83349541 |
6 | NIK/NF-kappaB signaling (GO:0038061) | 4.54494368 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.48701765 |
8 | detection of other organism (GO:0098543) | 4.20573506 |
9 | detection of bacterium (GO:0016045) | 4.12066042 |
10 | regulation of mast cell degranulation (GO:0043304) | 3.88272098 |
11 | cellular extravasation (GO:0045123) | 3.81575293 |
12 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.58169201 |
13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57531276 |
14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57408648 |
15 | detection of external biotic stimulus (GO:0098581) | 3.55502050 |
16 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.54255133 |
17 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49361611 |
18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.48724202 |
19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46907298 |
20 | response to host immune response (GO:0052572) | 3.46907298 |
21 | neutrophil activation involved in immune response (GO:0002283) | 3.46878032 |
22 | regulation of leukocyte degranulation (GO:0043300) | 3.46093197 |
23 | positive regulation of interferon-alpha production (GO:0032727) | 3.44167752 |
24 | positive regulation of mast cell activation (GO:0033005) | 3.43681039 |
25 | leukocyte aggregation (GO:0070486) | 3.38143273 |
26 | natural killer cell mediated immunity (GO:0002228) | 3.35252143 |
27 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.35252143 |
28 | myeloid cell activation involved in immune response (GO:0002275) | 3.34271978 |
29 | immunoglobulin mediated immune response (GO:0016064) | 3.33398135 |
30 | regulation of interferon-alpha production (GO:0032647) | 3.27622604 |
31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26303494 |
32 | response to muramyl dipeptide (GO:0032495) | 3.25374240 |
33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23007677 |
34 | detection of molecule of bacterial origin (GO:0032490) | 3.22490983 |
35 | response to host (GO:0075136) | 3.22205613 |
36 | response to host defenses (GO:0052200) | 3.22205613 |
37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22205613 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19092986 |
39 | myeloid dendritic cell differentiation (GO:0043011) | 3.18149943 |
40 | amino sugar catabolic process (GO:0046348) | 3.13863994 |
41 | regulation of mast cell activation (GO:0033003) | 3.13485886 |
42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.13172522 |
43 | detection of biotic stimulus (GO:0009595) | 3.12409929 |
44 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11447432 |
45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11423669 |
46 | positive regulation of mast cell degranulation (GO:0043306) | 3.11423669 |
47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10996185 |
48 | microglial cell activation (GO:0001774) | 3.07967093 |
49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07160704 |
50 | dendritic cell differentiation (GO:0097028) | 3.06940786 |
51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05183328 |
52 | regulation of necroptotic process (GO:0060544) | 3.01484646 |
53 | regulation of protein heterodimerization activity (GO:0043497) | 2.99879833 |
54 | positive thymic T cell selection (GO:0045059) | 2.98990677 |
55 | regulation of antigen processing and presentation (GO:0002577) | 2.98030919 |
56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97643164 |
57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.96853225 |
58 | modulation by symbiont of host defense response (GO:0052031) | 2.96853225 |
59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96853225 |
60 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.96853225 |
61 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.96853225 |
62 | modulation by symbiont of host immune response (GO:0052553) | 2.96853225 |
63 | myeloid dendritic cell activation (GO:0001773) | 2.96295253 |
64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95246265 |
65 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93113177 |
66 | macrophage activation (GO:0042116) | 2.91918622 |
67 | response to peptidoglycan (GO:0032494) | 2.90008549 |
68 | viral transcription (GO:0019083) | 2.88837330 |
69 | negative regulation of innate immune response (GO:0045824) | 2.88627213 |
70 | natural killer cell differentiation (GO:0001779) | 2.88466544 |
71 | positive regulation of B cell differentiation (GO:0045579) | 2.88397407 |
72 | pinocytosis (GO:0006907) | 2.87280924 |
73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87033584 |
74 | response to type I interferon (GO:0034340) | 2.86610825 |
75 | T cell apoptotic process (GO:0070231) | 2.84579409 |
76 | germinal center formation (GO:0002467) | 2.84090974 |
77 | type I interferon signaling pathway (GO:0060337) | 2.83756156 |
78 | cellular response to type I interferon (GO:0071357) | 2.83756156 |
79 | B cell mediated immunity (GO:0019724) | 2.81951706 |
80 | negative regulation of phagocytosis (GO:0050765) | 2.81715930 |
81 | response to interferon-alpha (GO:0035455) | 2.81170504 |
82 | T cell migration (GO:0072678) | 2.79831116 |
83 | negative regulation of interleukin-12 production (GO:0032695) | 2.78547204 |
84 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78179554 |
85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77008237 |
86 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.76955490 |
87 | ribosomal small subunit assembly (GO:0000028) | 2.75501900 |
88 | leukocyte degranulation (GO:0043299) | 2.75248374 |
89 | neutrophil activation (GO:0042119) | 2.74792084 |
90 | translational termination (GO:0006415) | 2.74775060 |
91 | negative regulation of interleukin-6 production (GO:0032715) | 2.74139811 |
92 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.73553446 |
93 | regulation of macrophage cytokine production (GO:0010935) | 2.71845622 |
94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71665514 |
95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71071733 |
96 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70078157 |
97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69975186 |
98 | regulation of superoxide anion generation (GO:0032928) | 2.69861333 |
99 | granulocyte activation (GO:0036230) | 2.69839577 |
100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69734914 |
101 | regulation of regulated secretory pathway (GO:1903305) | 2.69402022 |
102 | actin nucleation (GO:0045010) | 2.65219636 |
103 | regulation of RIG-I signaling pathway (GO:0039535) | 2.65027462 |
104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64856319 |
105 | regulation of integrin activation (GO:0033623) | 2.64704048 |
106 | T-helper 1 type immune response (GO:0042088) | 2.64164276 |
107 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.62711913 |
108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62333914 |
109 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62239952 |
110 | mannose metabolic process (GO:0006013) | 2.61701222 |
111 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.61464666 |
112 | mature B cell differentiation (GO:0002335) | 2.58681787 |
113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58449314 |
114 | regulation of B cell differentiation (GO:0045577) | 2.57924000 |
115 | platelet aggregation (GO:0070527) | 2.55343444 |
116 | cellular response to zinc ion (GO:0071294) | 2.55180089 |
117 | response to interferon-beta (GO:0035456) | 2.54964070 |
118 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54678254 |
119 | positive regulation of interferon-beta production (GO:0032728) | 2.54459139 |
120 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.52276264 |
121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49321887 |
122 | lymphocyte apoptotic process (GO:0070227) | 2.45900950 |
123 | regulation of interleukin-12 production (GO:0032655) | 2.45861094 |
124 | positive regulation of macrophage differentiation (GO:0045651) | 2.44233992 |
125 | negative regulation of necroptotic process (GO:0060546) | 2.43586955 |
126 | cell adhesion mediated by integrin (GO:0033627) | 2.43313178 |
127 | mature B cell differentiation involved in immune response (GO:0002313) | 2.43233233 |
128 | cellular response to interferon-alpha (GO:0035457) | 2.42079293 |
129 | translational elongation (GO:0006414) | 2.41916181 |
130 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.41268050 |
131 | hepatocyte apoptotic process (GO:0097284) | 2.40792765 |
132 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.39668099 |
133 | cellular response to interferon-beta (GO:0035458) | 2.38999527 |
134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38157265 |
135 | myeloid cell homeostasis (GO:0002262) | 2.37940256 |
136 | barbed-end actin filament capping (GO:0051016) | 2.36250098 |
137 | positive regulation of protein oligomerization (GO:0032461) | 2.34821467 |
138 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.34380115 |
139 | regulation of natural killer cell differentiation (GO:0032823) | 2.34078181 |
140 | regulation of necrotic cell death (GO:0010939) | 2.33815283 |
141 | macrophage activation involved in immune response (GO:0002281) | 2.32999091 |
142 | positive regulation of interleukin-12 production (GO:0032735) | 2.32920768 |
143 | defense response to protozoan (GO:0042832) | 2.31255471 |
144 | regulation of response to interferon-gamma (GO:0060330) | 2.31146697 |
145 | respiratory burst (GO:0045730) | 2.30535604 |
146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.29856290 |
147 | B cell receptor signaling pathway (GO:0050853) | 2.29634309 |
148 | lymphocyte mediated immunity (GO:0002449) | 2.29407980 |
149 | positive regulation of natural killer cell activation (GO:0032816) | 2.29185761 |
150 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.27593497 |
151 | leukocyte cell-cell adhesion (GO:0007159) | 2.27263488 |
152 | response to protozoan (GO:0001562) | 2.27221001 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.95395963 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49125872 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42618461 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.31232941 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79374329 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77753379 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76749765 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68065745 |
9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.67212396 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 2.58515647 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49798142 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47438638 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36020084 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31164620 |
15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28713440 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23809955 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19215408 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17877349 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11437334 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10494323 |
21 | MAF_26560356_Chip-Seq_TH1_Human | 2.00561683 |
22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.00131076 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99675958 |
24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98625551 |
25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.93846261 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93547021 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92926715 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88188289 |
29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.87966782 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.80104314 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79781219 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78179153 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78061019 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77352455 |
35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73120926 |
36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72262051 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71842585 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68855783 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66242340 |
40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65143136 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63115610 |
42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58603309 |
43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57690166 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57626524 |
45 | MYB_26560356_Chip-Seq_TH1_Human | 1.57386315 |
46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57296502 |
47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49508072 |
48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49238656 |
49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45403417 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42591019 |
51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42441222 |
52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42196224 |
53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42194116 |
54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42119259 |
55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40515986 |
56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39978921 |
57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38560592 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37336414 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36282333 |
60 | MAF_26560356_Chip-Seq_TH2_Human | 1.35764906 |
61 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34994828 |
62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33847660 |
63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31665001 |
64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31271352 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28032152 |
66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27473773 |
67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27355297 |
68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27259803 |
69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27062383 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26103016 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25666086 |
72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25161272 |
73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22650710 |
74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21753447 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20988403 |
76 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19188740 |
77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18628374 |
78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18339925 |
79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18136440 |
80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16958997 |
81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16628844 |
82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16346148 |
83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16206855 |
84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15770474 |
85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15079560 |
86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14088187 |
87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13961974 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13210400 |
89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13159636 |
90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13051279 |
91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12676698 |
92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11626476 |
93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10652749 |
94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09656569 |
95 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09624406 |
96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09371566 |
97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09331893 |
98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08355682 |
99 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07495052 |
100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07104910 |
101 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06409821 |
102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06183716 |
103 | P68_20966046_ChIP-Seq_HELA_Human | 1.06128814 |
104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05954793 |
105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05770192 |
106 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05142756 |
107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04108672 |
108 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01062324 |
109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01048294 |
110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00003892 |
111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99688006 |
112 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98679839 |
113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98268648 |
114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98161308 |
115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97719789 |
116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95886034 |
117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95589900 |
118 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.95460177 |
119 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95414014 |
120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94993402 |
121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94486877 |
122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94257268 |
123 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93770878 |
124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93460898 |
125 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92549311 |
126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92124797 |
127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92124797 |
128 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91117708 |
129 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90971082 |
130 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90110254 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.32141395 |
2 | MP0000685_abnormal_immune_system | 3.05716052 |
3 | MP0008438_abnormal_cutaneous_collagen | 2.85742503 |
4 | MP0003436_decreased_susceptibility_to | 2.71740772 |
5 | MP0003303_peritoneal_inflammation | 2.61481571 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.52046492 |
7 | MP0005387_immune_system_phenotype | 2.32339489 |
8 | MP0001790_abnormal_immune_system | 2.32339489 |
9 | MP0009785_altered_susceptibility_to | 2.32165167 |
10 | MP0005000_abnormal_immune_tolerance | 2.27324578 |
11 | MP0003705_abnormal_hypodermis_morpholog | 2.23034353 |
12 | * MP0002452_abnormal_antigen_presenting | 2.18421398 |
13 | * MP0001800_abnormal_humoral_immune | 2.17386674 |
14 | MP0005671_abnormal_response_to | 2.15886725 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.03351044 |
16 | MP0002166_altered_tumor_susceptibility | 2.01502998 |
17 | MP0005025_abnormal_response_to | 2.01492577 |
18 | MP0004510_myositis | 1.99198462 |
19 | * MP0002419_abnormal_innate_immunity | 1.98129851 |
20 | * MP0002723_abnormal_immune_serum | 1.96527257 |
21 | * MP0001819_abnormal_immune_cell | 1.91893543 |
22 | MP0001545_abnormal_hematopoietic_system | 1.91698071 |
23 | MP0005397_hematopoietic_system_phenotyp | 1.91698071 |
24 | * MP0002420_abnormal_adaptive_immunity | 1.91218588 |
25 | MP0003300_gastrointestinal_ulcer | 1.88701790 |
26 | MP0002396_abnormal_hematopoietic_system | 1.88453735 |
27 | MP0003566_abnormal_cell_adhesion | 1.84189238 |
28 | MP0009333_abnormal_splenocyte_physiolog | 1.82731760 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.81870094 |
30 | * MP0002398_abnormal_bone_marrow | 1.80966032 |
31 | MP0006082_CNS_inflammation | 1.77635725 |
32 | MP0002405_respiratory_system_inflammati | 1.75709000 |
33 | MP0004808_abnormal_hematopoietic_stem | 1.74944227 |
34 | MP0005464_abnormal_platelet_physiology | 1.71104435 |
35 | MP0003279_aneurysm | 1.70176027 |
36 | MP0005058_abnormal_lysosome_morphology | 1.68129908 |
37 | MP0004947_skin_inflammation | 1.66109833 |
38 | MP0002006_tumorigenesis | 1.65592698 |
39 | MP0000858_altered_metastatic_potential | 1.65366407 |
40 | MP0001853_heart_inflammation | 1.64590960 |
41 | MP0001533_abnormal_skeleton_physiology | 1.64103757 |
42 | MP0008260_abnormal_autophagy | 1.63155970 |
43 | MP0003075_altered_response_to | 1.62214434 |
44 | * MP0000716_abnormal_immune_system | 1.60564839 |
45 | MP0010307_abnormal_tumor_latency | 1.59500553 |
46 | MP0003448_altered_tumor_morphology | 1.59143241 |
47 | MP0001348_abnormal_lacrimal_gland | 1.58485640 |
48 | MP0005023_abnormal_wound_healing | 1.56980573 |
49 | MP0003091_abnormal_cell_migration | 1.56762447 |
50 | MP0003828_pulmonary_edema | 1.55242729 |
51 | MP0009278_abnormal_bone_marrow | 1.50208125 |
52 | * MP0000689_abnormal_spleen_morphology | 1.49536903 |
53 | * MP0002722_abnormal_immune_system | 1.47661582 |
54 | * MP0002429_abnormal_blood_cell | 1.44894147 |
55 | MP0005451_abnormal_body_composition | 1.43681003 |
56 | MP0010155_abnormal_intestine_physiology | 1.42517600 |
57 | MP0000604_amyloidosis | 1.41517713 |
58 | MP0006054_spinal_hemorrhage | 1.36647085 |
59 | MP0002933_joint_inflammation | 1.35872340 |
60 | MP0001845_abnormal_inflammatory_respons | 1.35658163 |
61 | MP0000490_abnormal_crypts_of | 1.35369290 |
62 | MP0003763_abnormal_thymus_physiology | 1.35354662 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.34390106 |
64 | MP0001958_emphysema | 1.32820948 |
65 | MP0005076_abnormal_cell_differentiation | 1.32166578 |
66 | MP0003183_abnormal_peptide_metabolism | 1.32024870 |
67 | MP0001873_stomach_inflammation | 1.30263489 |
68 | MP0005275_abnormal_skin_tensile | 1.27045903 |
69 | MP0002138_abnormal_hepatobiliary_system | 1.25391840 |
70 | MP0003724_increased_susceptibility_to | 1.22881188 |
71 | MP0003172_abnormal_lysosome_physiology | 1.19575733 |
72 | MP0000343_altered_response_to | 1.19464361 |
73 | MP0001851_eye_inflammation | 1.18044393 |
74 | MP0002163_abnormal_gland_morphology | 1.17534682 |
75 | MP0002254_reproductive_system_inflammat | 1.12510424 |
76 | MP0003866_abnormal_defecation | 1.11188381 |
77 | MP0002998_abnormal_bone_remodeling | 1.09892971 |
78 | MP0003806_abnormal_nucleotide_metabolis | 1.08794692 |
79 | MP0008469_abnormal_protein_level | 1.08721833 |
80 | MP0005257_abnormal_intraocular_pressure | 1.08615382 |
81 | * MP0000703_abnormal_thymus_morphology | 1.08391131 |
82 | MP0005310_abnormal_salivary_gland | 1.06919352 |
83 | MP0005390_skeleton_phenotype | 1.05379179 |
84 | MP0000733_abnormal_muscle_development | 1.04791285 |
85 | MP0008007_abnormal_cellular_replicative | 1.02218907 |
86 | MP0002132_abnormal_respiratory_system | 1.00734686 |
87 | MP0009840_abnormal_foam_cell | 1.00475039 |
88 | MP0001243_abnormal_dermal_layer | 0.97717049 |
89 | MP0005166_decreased_susceptibility_to | 0.97341919 |
90 | MP0000465_gastrointestinal_hemorrhage | 0.96926726 |
91 | MP0009763_increased_sensitivity_to | 0.95978833 |
92 | * MP0002019_abnormal_tumor_incidence | 0.95480932 |
93 | MP0008004_abnormal_stomach_pH | 0.94965535 |
94 | MP0003453_abnormal_keratinocyte_physiol | 0.92718594 |
95 | MP0003693_abnormal_embryo_hatching | 0.92377912 |
96 | MP0004883_abnormal_blood_vessel | 0.92115835 |
97 | MP0000767_abnormal_smooth_muscle | 0.91460522 |
98 | MP0005164_abnormal_response_to | 0.89993029 |
99 | MP0001663_abnormal_digestive_system | 0.89984243 |
100 | MP0000015_abnormal_ear_pigmentation | 0.88778278 |
101 | MP0003077_abnormal_cell_cycle | 0.88093558 |
102 | MP0003690_abnormal_glial_cell | 0.87740549 |
103 | MP0005174_abnormal_tail_pigmentation | 0.82744343 |
104 | MP0005503_abnormal_tendon_morphology | 0.82461229 |
105 | MP0005623_abnormal_meninges_morphology | 0.81692681 |
106 | MP0005165_increased_susceptibility_to | 0.79600289 |
107 | MP0003045_fibrosis | 0.78704940 |
108 | MP0003795_abnormal_bone_structure | 0.77957759 |
109 | MP0003329_amyloid_beta_deposits | 0.75337460 |
110 | MP0003191_abnormal_cellular_cholesterol | 0.74934795 |
111 | MP0009764_decreased_sensitivity_to | 0.74403966 |
112 | MP0005621_abnormal_cell_physiology | 0.73957264 |
113 | MP0001915_intracranial_hemorrhage | 0.73815143 |
114 | MP0000249_abnormal_blood_vessel | 0.72956323 |
115 | * MP0000350_abnormal_cell_proliferation | 0.72518685 |
116 | MP0003111_abnormal_nucleus_morphology | 0.72409876 |
117 | MP0002060_abnormal_skin_morphology | 0.71987837 |
118 | MP0001542_abnormal_bone_strength | 0.70765120 |
119 | MP0000313_abnormal_cell_death | 0.70313547 |
120 | MP0008874_decreased_physiological_sensi | 0.66448438 |
121 | MP0009765_abnormal_xenobiotic_induced | 0.58547354 |
122 | MP0004185_abnormal_adipocyte_glucose | 0.56131810 |
123 | MP0005319_abnormal_enzyme/_coenzyme | 0.56042421 |
124 | MP0005381_digestive/alimentary_phenotyp | 0.55290703 |
125 | MP0000609_abnormal_liver_physiology | 0.53304186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 4.05137829 |
2 | Premature rupture of membranes (HP:0001788) | 3.80453313 |
3 | Peritonitis (HP:0002586) | 3.77384159 |
4 | Recurrent abscess formation (HP:0002722) | 3.70554284 |
5 | Eczematoid dermatitis (HP:0000976) | 3.69770846 |
6 | Vertebral compression fractures (HP:0002953) | 3.45353434 |
7 | Purpura (HP:0000979) | 3.42520334 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39540950 |
9 | Stomatitis (HP:0010280) | 3.31696697 |
10 | Recurrent bacterial skin infections (HP:0005406) | 3.26169802 |
11 | Chronic otitis media (HP:0000389) | 3.13553083 |
12 | Hepatosplenomegaly (HP:0001433) | 3.11283171 |
13 | Nasal polyposis (HP:0100582) | 3.06832233 |
14 | Thrombocytosis (HP:0001894) | 3.05588951 |
15 | Recurrent bronchitis (HP:0002837) | 3.05161553 |
16 | Myositis (HP:0100614) | 3.01611640 |
17 | Cellulitis (HP:0100658) | 3.00322582 |
18 | Recurrent viral infections (HP:0004429) | 3.00252952 |
19 | Recurrent fungal infections (HP:0002841) | 2.97397778 |
20 | Abnormality of the nasal mucosa (HP:0000433) | 2.89415360 |
21 | Cerebral aneurysm (HP:0004944) | 2.85346509 |
22 | Urticaria (HP:0001025) | 2.79701037 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78251453 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78251453 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78251453 |
26 | Abnormality of macrophages (HP:0004311) | 2.77639728 |
27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77138651 |
28 | Osteolytic defects of the hand bones (HP:0009699) | 2.76359286 |
29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.76359286 |
30 | Retrobulbar optic neuritis (HP:0100654) | 2.76025363 |
31 | Optic neuritis (HP:0100653) | 2.76025363 |
32 | Gingivitis (HP:0000230) | 2.75464097 |
33 | Increased density of long bones (HP:0006392) | 2.70651418 |
34 | Loss of speech (HP:0002371) | 2.65910011 |
35 | Hypertensive crisis (HP:0100735) | 2.63871783 |
36 | Cervical subluxation (HP:0003308) | 2.63247479 |
37 | Petechiae (HP:0000967) | 2.62024027 |
38 | Gingival bleeding (HP:0000225) | 2.61914438 |
39 | Encephalitis (HP:0002383) | 2.57451827 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.54361824 |
41 | Amyloidosis (HP:0011034) | 2.52056281 |
42 | Mediastinal lymphadenopathy (HP:0100721) | 2.52007295 |
43 | Dysostosis multiplex (HP:0000943) | 2.51749201 |
44 | Panhypogammaglobulinemia (HP:0003139) | 2.51153383 |
45 | Gastrointestinal stroma tumor (HP:0100723) | 2.50304680 |
46 | Dilatation of the ascending aorta (HP:0005111) | 2.48351537 |
47 | Hematochezia (HP:0002573) | 2.46976550 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.46489657 |
49 | Chest pain (HP:0100749) | 2.45335771 |
50 | Aortic dissection (HP:0002647) | 2.43915096 |
51 | Mucopolysacchariduria (HP:0008155) | 2.42908355 |
52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42908355 |
53 | Orchitis (HP:0100796) | 2.39082414 |
54 | Increased IgM level (HP:0003496) | 2.38656672 |
55 | Thoracolumbar scoliosis (HP:0002944) | 2.38496951 |
56 | Aortic aneurysm (HP:0004942) | 2.35866057 |
57 | Recurrent skin infections (HP:0001581) | 2.35491119 |
58 | Pustule (HP:0200039) | 2.34841383 |
59 | Vasculitis (HP:0002633) | 2.32166769 |
60 | Emphysema (HP:0002097) | 2.30732218 |
61 | Abnormality of iron homeostasis (HP:0011031) | 2.29683891 |
62 | J-shaped sella turcica (HP:0002680) | 2.28300720 |
63 | Beaking of vertebral bodies (HP:0004568) | 2.28259653 |
64 | Vacuolated lymphocytes (HP:0001922) | 2.24070679 |
65 | Myocardial infarction (HP:0001658) | 2.23980650 |
66 | Hemoptysis (HP:0002105) | 2.23040995 |
67 | Abnormality of the peritoneum (HP:0002585) | 2.22957806 |
68 | Fatigue (HP:0012378) | 2.20503577 |
69 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.19989789 |
70 | Increased cerebral lipofuscin (HP:0011813) | 2.19881012 |
71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18638620 |
72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18638620 |
73 | Upper motor neuron abnormality (HP:0002127) | 2.17054512 |
74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15892500 |
75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14669291 |
76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14669291 |
77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14669291 |
78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14619087 |
79 | Episodic fever (HP:0001954) | 2.13804874 |
80 | Abnormality of the acetabulum (HP:0003170) | 2.11057176 |
81 | Abnormal platelet volume (HP:0011876) | 2.10585864 |
82 | Ankle contracture (HP:0006466) | 2.10401409 |
83 | Abnormality of the lumbar spine (HP:0100712) | 2.09554597 |
84 | Restrictive lung disease (HP:0002091) | 2.08713706 |
85 | Colitis (HP:0002583) | 2.07608987 |
86 | Increased serum ferritin (HP:0003281) | 2.06014105 |
87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05648256 |
88 | Thoracic kyphosis (HP:0002942) | 2.05542612 |
89 | Biconcave vertebral bodies (HP:0004586) | 2.05445751 |
90 | Disinhibition (HP:0000734) | 2.05204944 |
91 | Gastrointestinal inflammation (HP:0004386) | 2.05010968 |
92 | Prolonged bleeding time (HP:0003010) | 2.04595675 |
93 | Pulmonary infiltrates (HP:0002113) | 2.04224432 |
94 | Inflammation of the large intestine (HP:0002037) | 2.03191844 |
95 | Polycythemia (HP:0001901) | 2.02491746 |
96 | Spondylolisthesis (HP:0003302) | 2.02054136 |
97 | Lymphopenia (HP:0001888) | 2.01926022 |
98 | Granulocytopenia (HP:0001913) | 2.01173154 |
99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00364623 |
100 | Obstructive lung disease (HP:0006536) | 2.00364623 |
101 | Genu recurvatum (HP:0002816) | 2.00199453 |
102 | Osteomyelitis (HP:0002754) | 1.99682899 |
103 | Abnormality of T cell physiology (HP:0011840) | 1.98782473 |
104 | Flat acetabular roof (HP:0003180) | 1.98725955 |
105 | Arterial thrombosis (HP:0004420) | 1.98570536 |
106 | Abnormal number of erythroid precursors (HP:0012131) | 1.98511285 |
107 | Epistaxis (HP:0000421) | 1.98042990 |
108 | Radial bowing (HP:0002986) | 1.96538667 |
109 | Keratoconjunctivitis sicca (HP:0001097) | 1.95861124 |
110 | Ulnar bowing (HP:0003031) | 1.94498809 |
111 | Abnormality of T cells (HP:0002843) | 1.93677608 |
112 | Meningitis (HP:0001287) | 1.93421199 |
113 | Leukocytosis (HP:0001974) | 1.92951600 |
114 | Hypergammaglobulinemia (HP:0010702) | 1.92234709 |
115 | Increased mean platelet volume (HP:0011877) | 1.91666716 |
116 | IgM deficiency (HP:0002850) | 1.91640794 |
117 | Gastrointestinal infarctions (HP:0005244) | 1.91551529 |
118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89804282 |
119 | Mitral valve prolapse (HP:0001634) | 1.89495476 |
120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89171953 |
121 | Arthralgia (HP:0002829) | 1.88721488 |
122 | Basal ganglia calcification (HP:0002135) | 1.88426037 |
123 | Periodontitis (HP:0000704) | 1.87335384 |
124 | Glomerulopathy (HP:0100820) | 1.86880949 |
125 | Spontaneous hematomas (HP:0007420) | 1.85752460 |
126 | Polygenic inheritance (HP:0010982) | 1.85304924 |
127 | Agammaglobulinemia (HP:0004432) | 1.85301171 |
128 | Increased IgE level (HP:0003212) | 1.84447643 |
129 | Recurrent pneumonia (HP:0006532) | 1.84384771 |
130 | Joint stiffness (HP:0001387) | 1.83917181 |
131 | Systemic lupus erythematosus (HP:0002725) | 1.83737886 |
132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83549861 |
133 | Abnormal platelet function (HP:0011869) | 1.83376861 |
134 | Impaired platelet aggregation (HP:0003540) | 1.83376861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.09972130 |
2 | NME2 | 2.92192446 |
3 | TRIB3 | 2.82524791 |
4 | ERN1 | 2.82227860 |
5 | TBK1 | 2.74771070 |
6 | TYK2 | 2.50714387 |
7 | FES | 2.41286274 |
8 | JAK3 | 2.40703466 |
9 | MAP3K14 | 2.38341145 |
10 | PRPF4B | 2.36599131 |
11 | PIM2 | 2.20226641 |
12 | MAP3K10 | 2.13076348 |
13 | EEF2K | 2.09524896 |
14 | PKN2 | 1.99434278 |
15 | LRRK2 | 1.97113321 |
16 | BLK | 1.96327396 |
17 | KIT | 1.94715519 |
18 | STK10 | 1.92052176 |
19 | RPS6KA4 | 1.91940919 |
20 | TTN | 1.86918826 |
21 | * IKBKB | 1.82841488 |
22 | TNK2 | 1.71387939 |
23 | IKBKE | 1.69147530 |
24 | SMG1 | 1.62685269 |
25 | ZAP70 | 1.54553924 |
26 | TESK2 | 1.53533032 |
27 | CSF1R | 1.51905740 |
28 | MAP2K3 | 1.51029059 |
29 | FLT3 | 1.50209039 |
30 | JAK1 | 1.49427710 |
31 | TGFBR2 | 1.43011283 |
32 | TESK1 | 1.38188347 |
33 | TAOK2 | 1.38136015 |
34 | MAP3K13 | 1.35753053 |
35 | BMX | 1.30896893 |
36 | CHUK | 1.30748835 |
37 | IRAK4 | 1.27539788 |
38 | SCYL2 | 1.25153686 |
39 | PIM1 | 1.23494456 |
40 | MAP3K11 | 1.22272582 |
41 | TRPM7 | 1.17634963 |
42 | PAK4 | 1.16855230 |
43 | BTK | 1.14113499 |
44 | MOS | 1.09354405 |
45 | EPHB1 | 1.08922631 |
46 | PRKD2 | 1.04822865 |
47 | NEK9 | 1.04487709 |
48 | HCK | 1.01554249 |
49 | SYK | 1.01515989 |
50 | MAP3K1 | 1.00638203 |
51 | GRK6 | 1.00626454 |
52 | KDR | 0.99107599 |
53 | CSK | 0.98989943 |
54 | RIPK4 | 0.98380729 |
55 | MAP3K8 | 0.97777299 |
56 | MATK | 0.97464465 |
57 | NEK2 | 0.95010988 |
58 | MAPKAPK3 | 0.94914718 |
59 | PTK6 | 0.91920787 |
60 | MAP3K3 | 0.87597708 |
61 | STK4 | 0.84405719 |
62 | TGFBR1 | 0.84390038 |
63 | EIF2AK1 | 0.83323343 |
64 | PAK2 | 0.81844930 |
65 | TXK | 0.80288759 |
66 | CDC42BPA | 0.79636124 |
67 | IRAK3 | 0.78456891 |
68 | FGFR4 | 0.78268233 |
69 | RPS6KB2 | 0.77471294 |
70 | ARAF | 0.76831524 |
71 | * LCK | 0.76751135 |
72 | BMPR2 | 0.76588331 |
73 | SIK3 | 0.74295163 |
74 | MAPKAPK2 | 0.73616198 |
75 | TEC | 0.73427838 |
76 | CDK6 | 0.72269171 |
77 | DDR2 | 0.71006181 |
78 | GRK7 | 0.70940021 |
79 | LYN | 0.69224212 |
80 | RPS6KL1 | 0.67406565 |
81 | RPS6KC1 | 0.67406565 |
82 | ILK | 0.67242523 |
83 | MAPK7 | 0.64843308 |
84 | JAK2 | 0.64796502 |
85 | PDPK1 | 0.64445066 |
86 | ICK | 0.63146072 |
87 | MARK3 | 0.61683348 |
88 | PDGFRA | 0.61486930 |
89 | PDK1 | 0.60287201 |
90 | PAK1 | 0.59088141 |
91 | KSR2 | 0.58822028 |
92 | MAPK12 | 0.57654682 |
93 | CDK12 | 0.57520984 |
94 | RIPK1 | 0.56970324 |
95 | TLK1 | 0.55706244 |
96 | BUB1 | 0.55541339 |
97 | MARK2 | 0.55220093 |
98 | CAMKK2 | 0.54913300 |
99 | EPHA3 | 0.54865349 |
100 | EPHA2 | 0.54682776 |
101 | MAP2K2 | 0.54469388 |
102 | TAOK1 | 0.52292852 |
103 | SIK2 | 0.51965057 |
104 | RAF1 | 0.51896078 |
105 | CDK4 | 0.51802115 |
106 | FGFR3 | 0.51536458 |
107 | IRAK1 | 0.51172421 |
108 | HIPK2 | 0.50876062 |
109 | MAPK11 | 0.49950620 |
110 | MAPK4 | 0.49489348 |
111 | CDK19 | 0.47521653 |
112 | PTK2B | 0.47239406 |
113 | PRKCQ | 0.46839968 |
114 | DYRK3 | 0.46698232 |
115 | TAOK3 | 0.46498298 |
116 | ITK | 0.46275500 |
117 | STK3 | 0.45948742 |
118 | DAPK3 | 0.45516819 |
119 | RPS6KA2 | 0.45136403 |
120 | PTK2 | 0.44561464 |
121 | PRKG2 | 0.44141661 |
122 | IRAK2 | 0.43463329 |
123 | FYN | 0.43159936 |
124 | PIK3CG | 0.42612196 |
125 | RPS6KA6 | 0.42128281 |
126 | LIMK1 | 0.41795956 |
127 | BCKDK | 0.41418387 |
128 | ABL2 | 0.41306804 |
129 | DYRK1B | 0.41223853 |
130 | MAP3K5 | 0.40690094 |
131 | ALK | 0.38477040 |
132 | SIK1 | 0.38379017 |
133 | EGFR | 0.36528980 |
134 | CLK1 | 0.36471533 |
135 | FGR | 0.34924476 |
136 | RPS6KA5 | 0.34620973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59647765 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28582277 |
3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01085451 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97591244 |
5 | * Measles_Homo sapiens_hsa05162 | 1.90824589 |
6 | Shigellosis_Homo sapiens_hsa05131 | 1.84450375 |
7 | Apoptosis_Homo sapiens_hsa04210 | 1.83810047 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83358939 |
9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81644888 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81154579 |
11 | Ribosome_Homo sapiens_hsa03010 | 1.79241945 |
12 | Malaria_Homo sapiens_hsa05144 | 1.77306556 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76430640 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74905900 |
15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72289257 |
16 | Legionellosis_Homo sapiens_hsa05134 | 1.66576816 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66009503 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64526763 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60703832 |
20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.58762269 |
21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58145290 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53736512 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52253781 |
24 | Allograft rejection_Homo sapiens_hsa05330 | 1.50416511 |
25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50358483 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.47276177 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.46705863 |
28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45763831 |
29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.45745625 |
30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44216877 |
31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42286644 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41923856 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38788656 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.36282553 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33221395 |
36 | DNA replication_Homo sapiens_hsa03030 | 1.32986901 |
37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32874931 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.32627636 |
39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30429395 |
40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29057805 |
41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28623129 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26087903 |
43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23167056 |
44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22789129 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21856139 |
46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20793945 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.20660064 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16319804 |
49 | Lysosome_Homo sapiens_hsa04142 | 1.15090828 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11150702 |
51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06593602 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05842471 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05401606 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02676387 |
55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98769486 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98415918 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98087987 |
58 | Bladder cancer_Homo sapiens_hsa05219 | 0.97992464 |
59 | Base excision repair_Homo sapiens_hsa03410 | 0.97942520 |
60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95690481 |
61 | Platelet activation_Homo sapiens_hsa04611 | 0.94384287 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.90657153 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90240544 |
64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89083118 |
65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88369196 |
66 | Focal adhesion_Homo sapiens_hsa04510 | 0.87811770 |
67 | Amoebiasis_Homo sapiens_hsa05146 | 0.86333221 |
68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86178997 |
69 | Proteasome_Homo sapiens_hsa03050 | 0.83689059 |
70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83183855 |
71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81753488 |
72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81679194 |
73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79663247 |
74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79113794 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78796489 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78744362 |
77 | Asthma_Homo sapiens_hsa05310 | 0.78398105 |
78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77027877 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75102325 |
80 | Hepatitis C_Homo sapiens_hsa05160 | 0.74814241 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73818591 |
82 | Cell cycle_Homo sapiens_hsa04110 | 0.72032284 |
83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71988256 |
84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69092536 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67516413 |
86 | Mismatch repair_Homo sapiens_hsa03430 | 0.66274259 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65552362 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64232271 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63901515 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61243373 |
91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59030203 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58286440 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58283585 |
94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57519852 |
95 | Endocytosis_Homo sapiens_hsa04144 | 0.56065876 |
96 | Homologous recombination_Homo sapiens_hsa03440 | 0.54987068 |
97 | Spliceosome_Homo sapiens_hsa03040 | 0.54050835 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52512418 |
99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52249855 |
100 | Adherens junction_Homo sapiens_hsa04520 | 0.50941577 |
101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49246357 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48157508 |
103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48109179 |
104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46356830 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46266918 |
106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46097510 |
107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45906616 |
108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45167904 |
109 | Prostate cancer_Homo sapiens_hsa05215 | 0.45149317 |
110 | RNA transport_Homo sapiens_hsa03013 | 0.44782568 |
111 | Prion diseases_Homo sapiens_hsa05020 | 0.44556320 |
112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42485244 |
113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42137028 |
114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42039114 |
115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41335824 |
116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40233002 |
117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40162767 |
118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34244207 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31973787 |
120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30894777 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26709895 |
122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24265433 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21594167 |
124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20681231 |